Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Unknown 3Completed 1

Sponsor Class

OTHER_GOV 2OTHER 2

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4

Conditions

Small Cell Lung Carcinoma 4Carcinoma, Non-Small-Cell Lung 2Neoplasms 1Lung Neoplasms 1

Interventions

Etoposide 156Carboplatin 146Cisplatin 106Topotecan 76durvalumab 52atezolizumab 51Irinotecan 45pembrolizumab 39Paclitaxel 34Nivolumab 33Radiotherapy 31PM 01183 25Drug Therapy 24anlotinib 23Gemcitabine 21apatinib 19Ipilimumab 18Docetaxel 17Temozolomide 16Platinum 16Radiosurgery 15Pemetrexed 14toripalimab 13tislelizumab 13olaparib 13Magnetic Resonance Spectroscopy 13Bevacizumab 13rovalpituzumab tesirine 11amrubicin 11Specimen Handling 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Small Cell Lung Carcinoma × Simvastatin × Thoracic × Clear all
NCT01441349 2022-04-06

Irinotecan/Cisplatin With or Without Simvastatin in Chemo-naive Patients With Extensive Disease-small Cell Lung Cancer

National Cancer Center, Korea

Phase 2 Unknown
192 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT04985201 2021-08-09

Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy

Shanghai Pulmonary Hospital, Shanghai, China

Phase 2 Unknown
40 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT04698941 2021-07-29

Combined Simvastatin and Albumin Paclitaxel in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy

Shanghai Pulmonary Hospital, Shanghai, China

Phase 2 Unknown
40 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT00452634 2013-06-19

Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC)

National Cancer Center, Korea

Phase 2 Completed
62 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡